MRMD
What one share of Marimed holds
Medicinal Chemicals and Botanical Products
We are a multi-state cannabis operator (“MSO”) in the United States, headquartered in Norwood, Massachusetts, dedicated to improving lives every day through our high-quality products, our actions, and our values. We develop, own, and manage seed to sale state-licensed, state-of-the-art, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis.
Marimed’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.41 |
|---|---|
| Profit | −$0.04 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.02 |
| Cash and investments | $0.02 |
| Debt | $0.21 |
| Book value | $0.11 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.05 | −$0.01 | $0.18 | −$0.17 | — | $0.06 |
| 2018 | $0.06 | −$0.07 | $0.05 | −$0.06 | — | $0.29 |
| 2019 | $0.22 | −$0.39 | $0.05 | −$0.16 | — | $0.03 |
| 2020 | $0.16 | $0.01 | $0.01 | −$0.00 | — | $0.03 |
| 2021 | $0.33 | $0.02 | $0.05 | $0.05 | — | $0.11 |
| 2022 | $0.35 | $0.04 | $0.03 | −$0.01 | — | $0.17 |
| 2023 | $0.41 | −$0.04 | $0.06 | −$0.03 | — | $0.18 |
| 2024 | $0.42 | −$0.03 | $0.03 | −$0.01 | — | $0.15 |
| 2025 | $0.41 | −$0.04 | $0.00 | $0.02 | — | $0.13 |